{"DataElement":{"publicId":"6270947","version":"1.1","preferredName":"Treatment Cohort Study EC10026 Code","preferredDefinition":"The code that represents the information pertaining to protocol 10026 in which subsets of a defined population are identified.","longName":"TX_COH_SDY_EC10026_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6270944","version":"1.1","preferredName":"EC10026 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"6270944v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"DL-1","valueDescription":"DL-1: Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5; Ind: (Cycles 1-4) Ipi 1mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main:  (Cycles 5-12) Ipi 1mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine","ValueMeaning":{"publicId":"6617441","version":"1","preferredName":"DL-1: Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5; Ind: (Cycles 1-4) Ipi 1mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main:  (Cycles 5-12) Ipi 1mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine","longName":"6617441","preferredDefinition":"DL-1: Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5; Ind: (Cycles 1-4) Ipi 1mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main:  (Cycles 5-12) Ipi 1mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAD7BF0-8B14-5B07-E053-F662850AE903","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FAD7BF0-8B2D-5B07-E053-F662850AE903","beginDate":"2019-01-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"DL2","valueDescription":"DL2:Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5; Ind: (Cycles 1-4) Ipi 10mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main:  (Cycles 5-12) Ipi 10mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine 20mg/m2 IV/60 min d1-5","ValueMeaning":{"publicId":"6617440","version":"1","preferredName":"DL2:Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5; Ind: (Cycles 1-4) Ipi 10mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main:  (Cycles 5-12) Ipi 10mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine 20mg/m2 IV/60 min d1-5","longName":"6617440","preferredDefinition":"DL2:Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5;\r\nInd: (Cycles 1-4) Ipi 10mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main:  (Cycles 5-12) Ipi 10mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine 20mg/m2 IV/60 min d1-5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAD7BF0-8AF1-5B07-E053-F662850AE903","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FAD7BF0-8B0A-5B07-E053-F662850AE903","beginDate":"2019-01-17","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"DL0","valueDescription":"DL0: Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5; Ind: (Cycles 1-4) Ipi 3mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main: (Cycles 5-12) Ipi 3mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine 20mg/m2 IV/60 min d1-5","ValueMeaning":{"publicId":"6687984","version":"1","preferredName":"DL0: Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5; Ind: (Cycles 1-4) Ipi 3mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main: (Cycles 5-12) Ipi 3mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine 20mg/m2 IV/60 min d1-5","longName":"6687984","preferredDefinition":"DL0: Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5; Ind: (Cycles 1-4) Ipi 3mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main: (Cycles 5-12) Ipi 3mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine 20mg/m2 IV/60 min d1-5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8608A3E2-514A-3EB8-E053-F662850AD3A8","latestVersionIndicator":"Yes","beginDate":"2019-04-08","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-08","modifiedBy":"ONEDATA","dateModified":"2019-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8608A3E2-5163-3EB8-E053-F662850AD3A8","beginDate":"2019-04-08","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-08","modifiedBy":"ONEDATA","dateModified":"2019-04-08","deletedIndicator":"No"},{"value":"DL1","valueDescription":"DL1: Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5; Ind: (Cycles 1-4) Ipi 5mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main: (Cycles 5-12) Ipi 5mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine 20mg/m2 IV/60 min d1-5","ValueMeaning":{"publicId":"6687983","version":"1","preferredName":"DL1: Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5; Ind: (Cycles 1-4) Ipi 5mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main: (Cycles 5-12) Ipi 5mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine 20mg/m2 IV/60 min d1-5","longName":"6687983","preferredDefinition":"DL1: Priming (Lead in) Decitabine: 20mg/m2 IV/60 min d1-5; Ind: (Cycles 1-4) Ipi 5mg/kg IV/90 min day 1 & Decitabine 20mg/m2 IV/60 min d1-5; Main: (Cycles 5-12) Ipi 5mg/kg IV/90 min d1 of cycles 5, 7, 9, & 11, Decitabine 20mg/m2 IV/60 min d1-5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8608A3E2-5127-3EB8-E053-F662850AD3A8","latestVersionIndicator":"Yes","beginDate":"2019-04-08","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-08","modifiedBy":"ONEDATA","dateModified":"2019-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8608A3E2-5140-3EB8-E053-F662850AD3A8","beginDate":"2019-04-08","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-08","modifiedBy":"ONEDATA","dateModified":"2019-04-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAD7BF0-8A96-5B07-E053-F662850AE903","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":"2019-01-17","createdBy":"SOKKERL","dateCreated":"2019-01-17","modifiedBy":"SOKKERL","dateModified":"2019-04-08","changeDescription":"version 1.1 deleted PV and added new PV. 4/8/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Treatment cohort","type":"Preferred Question Text","description":"Treatment cohort","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8608AEB6-617B-4A11-E053-F662850AA938","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-04-08","modifiedBy":"SOKKERL","dateModified":"2019-04-08","changeDescription":"Version VD. 4/8/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}